{"ParsedSentences":["(X (X 590782388) (X |) (X OH) (X |) (X 87702030) (X |) (X |) (X 4145081) (X |) (X 10/21/2005) (X 12:00:00) (X AM) (X |) (X right) (X MCA) (X stroke) (X |) (X |) (X DIS) (X |) (X Admission) (X Date) (X :) (X 10/21/2005) (X Report) (X Status) (X :) (X Discharge) (X Date) (X :) (X 6/18/2005) (X ******) (X FINAL) (X DISCHARGE) (X ORDERS) (X ******) (X TREVETHAN) (X ,) (X JERALD) (X 185-13-97-9VilleService) (X :) (X NEUDISCHARGE) (X PATIENT) (X ON) (X :) (X 9/19/05) (X AT) (X 02:00) (X PMCONTINGENT) (X UPON) (X Not) (X ApplicableWILL) (X D/C) (X ORDER) (X BE) (X USED) (X AS) (X THE) (X D/C) (X SUMMARY) (X :) (X YESAttending) (X :) (X BRANSCUM) (X ,) (X BRENTON) (X ,) (X M.D.CODE) (X STATUS) (X :) (X Full) (X codeDISPOSITION) (X :) (X RehabilitationDISCHARGE) (X MEDICATIONS) (X :) (X CIPROFLOXACIN) (X 500) (X MG) (X PO) (X Q12H) (X X) (X 10) (X dosesFood/Drug) (X Interaction) (X InstructionAdminister) (X iron) (X products) (X a) (X minimum) (X of) (X 2) (X hours) (X before) (X orafter) (X a) (X levofloxacin) (X or) (X ciprofloxacin) (X dose) (X doseIf) (X on) (X tube) (X feeds) (X ,) (X please) (X cycle) (X -LRB-) (X hold) (X 1) (X hr) (X before) (X to) (X 2) (X hrafter) (X -RRB-) (X Take) (X 2) (X hours) (X before) (X or) (X 2) (X hours) (X after) (X dairy) (X products.DEXTROAMPHETAMINE) (X SULFATE) (X 10) (X MG) (X PO) (X QDCOLACE) (X -LRB-) (X DOCUSATE) (X SODIUM) (X -RRB-) (X 100) (X MG) (X PO) (X BIDINSULIN) (X REGULAR) (X HUMANSliding) (X Scale) (X -LRB-) (X subcutaneously) (X -RRB-) (X SC) (X TIDIf) (X BS) (X is) (X less) (X than) (X 125) (X ,) (X then) (X give) (X 0) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 125-150) (X ,) (X then) (X give) (X 2) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 151-200) (X ,) (X then) (X give) (X 3) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 201-250) (X ,) (X then) (X give) (X 4) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 251-300) (X ,) (X then) (X give) (X 6) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 301-350) (X ,) (X then) (X give) (X 8) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 351-400) (X ,) (X then) (X give) (X 10) (X units) (X subcutaneously) (X andcall) (X HO) (X Call) (X HO) (X if) (X BS) (X is) (X greater) (X than) (X 400LEVOTHYROXINE) (X SODIUM) (X 125) (X MCG) (X PO) (X QDATIVAN) (X -LRB-) (X LORAZEPAM) (X -RRB-) (X 0.5) (X MG) (X PO) (X Q4H) (X PRN) (X AnxietyMETOPROLOL) (X TARTRATE) (X 12.5) (X MG) (X PO) (X BID) (X HOLD) (X IF) (X :) (X SBP) (X \u003c) (X 120Food/Drug) (X Interaction) (X InstructionTake) (X consistently) (X with) (X meals) (X or) (X on) (X empty) (X stomach.SENNA) (X TABLETS) (X -LRB-) (X SENNOSIDES) (X -RRB-) (X 2) (X TAB) (X PO) (X BIDSIMVASTATIN) (X 20) (X MG) (X PO) (X QHSFood/Drug) (X Interaction) (X InstructionAvoid) (X grapefruit) (X unless) (X MD) (X instructs) (X otherwise.REMERON) (X -LRB-) (X MIRTAZAPINE) (X -RRB-) (X 7.5) (X MG) (X PO) (X QHSNumber) (X of) (X Doses) (X Required) (X -LRB-) (X approximate) (X -RRB-) (X :) (X 5LAMICTAL) (X -LRB-) (X LAMOTRIGINE) (X -RRB-) (X 200) (X MG) (X PO) (X BIDNumber) (X of) (X Doses) (X Required) (X -LRB-) (X approximate) (X -RRB-) (X :) (X 5CLOPIDOGREL) (X 75) (X MG) (X PO) (X QD) (X Starting) (X Today) (X -LRB-) (X 11/24) (X -RRB-) (X HOLD) (X IF) (X :) (X plt) (X count) (X \u003c) (X 100DUONEB) (X -LRB-) (X ALBUTEROL) (X AND) (X IPRATROPIUM) (X NEBULIZER) (X -RRB-) (X 3/0) (X .5) (X MG) (X NEB) (X Q6H) (X PRN) (X Shortness) (X of) (X BreathNIASPAN) (X -LRB-) (X NICOTINIC) (X ACID) (X SUSTAINED) (X RELEASE) (X -RRB-) (X 0.5) (X GM) (X PO) (X QHSStarting) (X Today) (X -LRB-) (X 11/24) (X -RRB-) (X HOLD) (X IF) (X :) (X myalgiasAlert) (X overridden) (X :) (X Override) (X added) (X on) (X 9/19/05) (X by) (X :) (X POTENTIALLY) (X SERIOUS) (X INTERACTION) (X :) (X SIMVASTATIN) (X \u0026) (X NIACIN) (X ,) (X VIT) (X .))","(ROOT (S (S (NP (NP (NNP B-3) (NNP Reason)) (PP (IN for) (NP (NN override)))) (: :) (VP (MD will) (VP (VB monitorSALT) (NP (NP (NP (NNP TABLET)) (PRN (-LRB- -LRB-) (NP (NNP SODIUM) (NNP CHLORIDE)) (-RRB- -RRB-)) (NP (CD 1) (NNP GM) (NNP PO) (NNP BIDDIET))) (: :) (NP (NP (NP (NP (NNP Mechanical) (NNP Soft/Thin)) (PRN (-LRB- -LRB-) (NP (DT no) (NN consistency) (NN restriction)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP FDI)) (-RRB- -RRB-))) (NP (NNP DIET))))))) (: :) (S (NP (NNP House) (NNP /) (NNP Low) (NNP chol/low)) (VP (VBD sat))) (. .)))","(X (X fatDIET) (X :) (X House) (X /) (X ADA) (X 2100) (X cals/dyRETURN) (X TO) (X WORK) (X :) (X Not) (X ApplicableFOLLOW) (X UP) (X APPOINTMENT) (X -LRB-) (X S) (X -RRB-) (X :) (X Dr.) (X Hegg) (X ,) (X MHS) (X 622-840-9570) (X 2) (X weeks) (X ,) (X PCP) (X Dr.) (X Babiracki) (X 547-466-8501) (X 3-4) (X weeks) (X ,) (X Neurologist) (X Dr.) (X Stencil) (X ASAP) (X ,) (X Oncologist) (X Dr.) (X Calvello) (X as) (X previously) (X determined) (X ,) (X ALLERGY) (X :) (X Demerol) (X ,) (X Penicillins) (X ,) (X Codeine) (X ,) (X Sulfa) (X ,) (X IV) (X Contrast) (X ,) (X LEVETIRACETAM) (X ,) (X DIVALPROEX) (X SODIUMADMIT) (X DIAGNOSIS) (X :) (X strokePRINCIPAL) (X DISCHARGE) (X DIAGNOSIS) (X ;) (X Responsible) (X After) (X Study) (X for) (X Causing) (X Admission) (X -RRB-) (X right) (X MCA) (X strokeOTHER) (X DIAGNOSIS) (X ;) (X Conditions) (X ,) (X Infections) (X ,) (X Complications) (X ,) (X affecting) (X Treatment/Staysevere) (X right) (X internal) (X carotid) (X artery) (X stenosisnon-small) (X cell) (X lung) (X cancer) (X ,) (X pancytopenia) (X secondary) (X to) (X chemotherapyhypertension) (X ,) (X dyslipidemia) (X ,) (X type) (X 2) (X diabetes) (X mellitus) (X epilepsychronic) (X obstructive) (X pulmonary) (X disease) (X hypothyroidism) (X -LRB-) (X post-Graves) (X \u0027) (X disease) (X -RRB-) (X SIADHOPERATIONS) (X AND) (X PROCEDURES) (X :) (X OTHER) (X TREATMENTS/PROCEDURES) (X -LRB-) (X NOT) (X IN) (X O.R.) (X -RRB-) (X MRI/MRA) (X head) (X and) (X neckCT/CTA) (X head) (X and) (X necknoncontrast) (X head) (X CT) (X x) (X 4video) (X swallowing) (X studytransthoracic) (X echocardiogramBRIEF) (X RESUME) (X OF) (X HOSPITAL) (X COURSE) (X :) (X This) (X 64) (X year-old) (X right-handed) (X woman) (X presented) (X after) (X being) (X found) (X down) (X andweak) (X on) (X the) (X left) (X .))","(ROOT (S (NP (PRP She)) (VP (VP (VBZ has) (NP (NP (DT a) (JJ recent) (NN diagnosis)) (PP (IN of) (NP (JJ non-small) (NN cell) (NN lungcancer))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBG receiving) (NP (NN chemotherapy) (CC and) (NN radiation) (NNS therapytreatments)))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD presented) (PP (IN outside) (NP (DT the) (NN window))) (PP (IN for) (NP (JJ thrombolysis) (NN orintervention)))) (. .)))","(ROOT (S (NP (NNP Exam)) (VP (VBD revealed) (NP (NP (NN plegia)) (PP (IN of) (NP (NP (DT the) (JJ left) (NN face) (CC and) (NN arm)) (, ,) (NP (JJ paresis) (JJ ofthe) (NN left) (NN leg)) (, ,) (CC and) (NP (DT an) (JJ incomplete) (NN neglect) (NN syndrome)))))) (. .)))","(ROOT (S (S (NP (NNP MRI/MRA)) (VP (VP (VBP revealedpartial) (NP (ADJP (RB right)) (NNP MCA) (NN territory) (NN stroke))) (CC and) (VP (VBD suggested) (NP (JJ severe) (JJ proximal) (NN rightICA) (NNS stenosis))))) (: ;) (S (NP (PRP she)) (VP (VBD was) (VP (VBN placed) (PP (IN on) (NP (NN heparin)))))) (. .)))","(ROOT (S (NP (NP (NNS Antihypertensives)) (, ,) (ADVP (RB aside)) (NP (JJ fromlow-dose) (NN metoprolol)) (, ,)) (VP (VBD were) (VP (VBN held))) (. .)))","(ROOT (S (NP (NNP CT/CTA)) (VP (VP (ADVP (NN head) (CC and) (NN neck)) (NP-TMP (DT the) (JJ following)) (VP (VBD dayconfirmed) (NP (DT a) (JJ severe) (NN proximal)) (PP (RB right) (NP (NNP ICA) (NNS stenosis))))) (CC and) (VP (VBD revealed) (NP (NN evolution) (NN ofthe) (NN stroke)) (S (VP (TO to) (VP (VB involve) (NP (NP (RB much)) (PP (IN of) (NP (DT the) (JJ right) (NNP MCA) (NN territory))))))))) (. .)))","(ROOT (S (NP (NP (DT The) (NN heparin) (NN wasdiscontinued)) (CC and) (NP (DT the) (NN patient))) (VP (VBD placed) (ADVP (RB back)) (PP (IN on) (NP (NN clopidogrel)))) (. .)))","(ROOT (S (NP (DT The) (NNP Hoaggan) (NNP Memorial) (NNP Hospitalunder) (NNP Dr.) (NNP Aiu)) (VP (VP (VBZ evaluated) (NP (DT the) (NN patient))) (CC and) (VP (VBD recommended) (NP (DT a) (NN follow-upappointment)) (PP (IN with) (NP (PRP him))) (SBAR (NP (CD two) (NNS weeks)) (IN after) (S (NP (NP (JJ discharge.Laboratory) (NN work-up)) (ADJP (JJ pertinent) (PP (TO to) (NP (NN stroke))))) (VP (VBD revealed) (NP (NP (DT a) (JJ normal) (NN homocysteine)) (, ,) (NP (JJ normal) (NN TSH)) (, ,) (NP (NP (NN lipid) (NN profile)) (PP (IN with) (NP (NNP LDL) (CD 108)))) (, ,) (NP (NNP HDL) (CD 52)) (, ,) (NP (NNP TG) (CD 131)) (, ,) (CC and) (NP (NP (NNP Lp)) (PRN (-LRB- -LRB-) (X (SYM a)) (-RRB- -RRB-)) (SBAR (S (NP (NN lipoprotein)) (VP (VBD elevated) (PP (IN at) (NP (CD 93))))))))))))) (. .)))","(ROOT (S (S (NP (PRP She)) (VP (VBD was) (VP (VBN continued) (PP (IN on) (NP (DT a) (NN statin)))))) (, ,) (CC and) (S (NP (NN low-doseniacin)) (VP (VBD added) (PP (TO to) (NP (NP (DT the) (NN regimen)) (PP (RB because) (IN of) (NP (DT the) (NNP Lp) (PRN (-LRB- -LRB-) (X (SYM a)) (-RRB- -RRB-)) (NNS results))))))) (. .)))","(ROOT (S (S (NP (NP (PRP$ Her) (NNS hemoglobinA1c)) (CC and) (NP (JJ random) (NN blood) (NNS sugars))) (VP (VBD were) (ADJP (JJ elevated)))) (: ;) (S (NP (PRP she)) (VP (VBD received) (NP (DT an) (VBG insulinsliding) (NN scale)))) (. .)))","(ROOT (S (S (NP (NNP Echocardiogram)) (VP (VBD showed) (NP (JJ normal) (NN LVEF) (CC and) (NN size)) (PRN (, ,) (S (NP (DT no) (NN wall)) (VP (VBZ motionabnormalities))) (, ,)) (NP (NP (JJ +) (NN evidence)) (PP (IN of) (NP (JJ diastolic) (NN dysfunction)))))) (, ,) (CC and) (S (NP (JJ normal) (NNP LA) (NN size.Her) (NN cell) (NNS counts)) (VP (VBD trended) (ADVP (RB downward)) (PP (IN in) (NP (NP (DT an) (JJ expected) (NN fashion)) (VP (VBN given) (NP (DT the) (NN timingof)) (NP (PRP$ her) (ADJP (RBS most) (JJ recent)) (NN chemotherapy))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN placed) (PP (IN on) (NP (NNS neutropenicprecautions))))) (. .)))","(ROOT (S (NP (PRP$ Her) (NN oncologist) (NNP Dr.) (NNP Batrez)) (VP (VBD recommended) (NP (NP (JJ administeringprophylactic) (NN ciprofloxacin)) (CC and) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (JJ long-acting) (NNS G-CSF)))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBP isnot) (ADJP (VBN planned) (S (VP (TO to) (VP (VB receive) (NP (DT any) (JJ additional) (ADJP (JJ chemotherapeutic) (CC or) (JJ radiationtherapy)) (NNS treatments)) (PP (IN in) (NP (NP (DT the) (JJ near) (NN future.Her)) (SBAR (S (NP (JJ neurological) (NN examination)) (VP (VBD remained) (ADJP (JJ stable)))))))))))) (. .)))","(ROOT (S (S (NP (NP (NN Repeat) (NN head) (NN CTs)) (VP (VBN done) (NP (NNS toassess)) (PP (IN for) (NP (NP (NN edema)) (PP (VBG following) (NP (DT the) (NN stroke))))))) (VP (VBD revealed) (NP (NP (DT some) (NN effacement)) (PP (IN of) (NP (JJ theright) (JJ lateral) (NN ventricle)))))) (, ,) (CC but) (S (NP (DT no) (JJ threatening) (JJ mass) (NN effect.Her) (NN serum) (NN sodium)) (VP (VBD trended) (PRT (RP down)) (PP (IN throughout) (NP (NN admission))))) (: ;) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ recommendedthat)) (SBAR (SBAR (S (NP (PRP she)) (RB not) (VP (VB receive) (NP (JJ hypotonic) (NNS fluids)) (PP (IN at) (NP (NN rehab)))))) (CC and) (SBAR (IN that) (S (NP (PRP she)) (VP (VP (VB be) (VP (VBN waterrestricted) (PP (TO to) (NP (NP (CD 1L)) (PP (IN per) (NP (NN day))))))) (, ,) (CC and) (VP (VB take) (NP (NN salt)) (PP (IN as) (NP (NN directed.Given) (PRP$ her) (NN thrombocytopenia)))))))))) (, ,) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (JJ antiplatelet) (NN therapywith) (NN clopidogrel)) (VP (VB be) (VP (VBN held) (PP (IN until) (NP (PRP$ her) (JJ platelet) (NN count) (NNS rises))) (PP (IN over) (NP (CD 100)))))))))) (. .)))","(ROOT (S (NP (PRP It)) (ADVP (RB isalso)) (VP (VBD recommended) (NP (DT that) (NN anticoagulation)) (PP (IN with) (NP (NP (JJ therapeutic) (JJ low-molecularweight) (NN heparin)) (PP (IN as) (NP (NN bridge))))) (S (VP (TO to) (VP (VB warfarin) (PP (IN with) (NP (NN target) (NNP INR) (CD 2-3))) (S (VP (VB be) (VP (VBN restarted) (NP (NNS 2weeks)) (PP (IN after) (NP (PRP$ her) (NN stroke))) (, ,) (PP (IN on) (NP (CD 2/16/05)))))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (MD should) (VP (VB follow) (PRT (RP up)) (NP (NP (JJ forneurological) (NNS issues)) (PP (IN with) (NP (NP (NNP Dr.) (NNP Sagan)) (PP (IN of) (NP (NP (ADJP (JJ neurosurgery) (CONJP (RB as) (RB well) (IN as)) (JJ heroutpatient)) (NN neurologist)) (, ,) (NP (NNP Dr.) (NNP Collin) (NNP Krauskopf)) (, ,)))))) (PP (IN at) (NP (NP (NNP Cako) (NNP HospitalADDITIONAL) (NNP COMMENTS)) (: :) (NP (NNP DISCHARGE) (NNP CONDITION)) (: :) (NP (NNP FairTO) (NNP DO/PLAN) (NNP :1)))))) (. .)))","(ROOT (S (VP (VB hold) (ADJP (JJ clopidogrel) (PP (IN until) (NP (NN plt) (NN \u003e) (NNS 100k2))))) (. .)))","(ROOT (S (VP (VP (VB start) (NP (NP (JJ low-molecular) (NN weight) (NN heparin)) (PP (IN as) (NP (DT a) (NN bridge)))) (PP (TO to) (NP (NP (NN warfarin)) (PRN (-LRB- -LRB-) (NP (NN target) (NN INR2-3)) (-RRB- -RRB-))))) (CC and) (VP (VB discontinue) (ADJP (JJ clopidogrel) (NP-TMP (CD 7/1/053))))) (. .)))","(ROOT (S (NP (JJ Free) (NN water)) (VP (VBP restrict) (NP (NP (CD 1L)) (PP (IN per) (NP (NN day)))) (, ,) (S (VP (VB follow) (NP (NN serum) (NN sodium) (CD .4))))) (. .)))","(ROOT (S (VP (VB Follow) (PRT (RP up)) (PP (IN with) (NP (NNP Dr.) (NNP Amoah))) (PP (IN in) (NP (NP (CD 2) (NN weeks.No)) (VP (VBN dictated) (NP (NP (JJ summaryENTERED) (NN BY)) (: :) (NP (NP (NNP NAPOLITANO)) (, ,) (NP (NNP CLINT) (NNP RAY)) (, ,) (NP (NP (NNP M.D.)) (PRN (-LRB- -LRB-) (NP (NNP IQ99)) (-RRB- -RRB-)) (NP (CD 9/19/05) (CD @) (CD 02) (NNP ******) (NNP END))) (PP (IN OF) (NP (NNP DISCHARGE) (NNP ORDERS) (NNP ******)))))))))))"]}
